A scalable platform for commercialization of two-dimensional electronic spectroscopy

光谱学作为科学研究工具和工业过程的表征工具无处不在。一维（一个频率变量）光谱学中的一个常见问题是，由于拥塞，光谱特征是不可分辨的，从而使诊断无用。在这里，我们为这个长期存在的问题提出了一个强大而强大的解决方案，这将导致世界上第一台商用2D电子光谱仪。 技术背景：几十年前，核磁共振（NMR）社区通过2D-NMR提供了一种解决光谱拥塞问题的方法。商业2D-NMR光谱仪（例如布鲁克）现在在大多数化学部门，成本为50万至500万美元。为了探测更高的光学频率，可以使用商业FTIR和UV-VIS。最近，超快时间分辨1D光谱仪已经商业化：www.ultrafastsystems.com。目前还缺乏的是一种商业上的光学频率2D-NMR：二维电子光谱仪。二维电子光谱商业化的障碍是实验的巨大复杂性。 在这里，我们将创建一个统一的平台，以满足这个新兴科学市场空间中所有可能的客户需求。我们的解决方案可以轻松扩展到三种配置，可以执行所有可能的2DE实验，从而实现性价比优化，以满足市场需求。 预期成果：现在有机会成为第一个将这种光谱工具商业化的公司。这种工具对全球研究人员和工业用户具有吸引力，单位成本约为300，000美元，与布鲁克现在销售的NMR仪器没有什么不同。NSERC I2 I将使我们能够利用这一机会，为在将技术授权给工业合作伙伴之前进行必要的最终诊断和优化过程所需的人员提供资金。由于已经确定了当地合作伙伴，我们预计HQP在这一领域的积极合作和培训。

Spectroscopy is ubiquitous as a research tool in science and a characterization tool for industrial processes. A common problem in one dimensional (one frequency variable) spectroscopy is that the spectral features are unresolvable due to congestion, thus rendering the diagnostic useless. Here, we present a powerful and robust solution to this longstanding problem that will result in the World's first commercial 2D Electronic Spectrometer. Background of the technology: Decades ago, the nuclear magnetic resonance (NMR) community provided a solution to the spectral congestion problem via 2D-NMR. Commercial 2D-NMR spectrometers (e.g. Bruker) are in most Chemistry departments now, costing $0.5 - $5M. In order to probe higher optical frequencies, commercial FTIR and UV-VIS are available. Very recently, ultrafast time resolved 1D spectrometers have been commercialized: www.ultrafastsystems.com. What remains lacking is a commercial equivalent of 2D-NMR for optical frequencies: a Two Dimensional Electronic Spectrometer. The barrier to commercialization of 2D electronic spectroscopy has been the enormous complexity of the experiment. Here, we will create a unified platform for performing meeting all possible customer needs in this emergent scientific market space. Our solution is easily scalable to three configurations that that can perform all possible 2DE experiments, thereby enabling price/performance optimization to meet the market needs. Anticipated outcomes: The opportunity now exists to be the first to commercialize this spectroscopy tool. Such a tool would be attractive to researchers and industrial users worldwide, with a unit cost of ~$300,000, not unlike NMR instruments now sold by Bruker. The NSERC I2I will enable us to capitalize upon this opportunity by providing funding for personnel required to carry out the final diagnostic and optimization processes necessary before licensing the technology to an industrial partner. Since a local partner has been identified, we anticipate active collaboration and training of HQP in this space.